IBOV 177,999.00 ▲ 0.47% IPSA 11,016.85 ▼ 0.13% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,291,323 ▼ 0.41% COLCAP 2,392.10 ▲ 2.12% BVL PERÚ 57,890.85 — — USD/BRL5.07▼ 0.02% USD/MXN17.30▼ 0.26% USD/CLP 930.47 — 0.00% USD/COP3,148▼ 0.08% USD/PEN3.40▲ 0.15% USD/ARS1,485▼ 0.03% USD/UYU 40.20 — 0.00% USD/PYG 5,931 — 0.00% USD/BOB 12.10 — 0.00% USD/DOP58.11▲ 0.21% USD/CRC 448.40 — 0.00% USD/GTQ 7.62 — 0.00% USD/HNL 26.76 — 0.00% USD/NIO 36.62 — 0.00% USD/VES746.91▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.49▲ 0.19% USD/TTD6.72— 0.00% EUR/BRL5.86▲ 0.20% BRENT 90.12 ▲ 1.22% WTI 80.79 ▼ 4.58% IRON ORE 161.91 — — COPPER 6.54 ▲ 1.60% GOLD 4,132 ▲ 2.05% SILVER 58.52 ▲ 1.61% SOY 1,183 ▲ 0.90% CORN 460.75 ▲ 4.54% WHEAT 632.50 ▼ 1.06% COFFEE 313.55 ▼ 2.94% SUGAR 14.65 ▲ 1.52% ORANGE JUICE 153.35 ▲ 5.03% COTTON 81.20 ▲ 2.25% COCOA 5,537 ▲ 8.31% BEEF 227.25 ▼ 1.72% CATTLE 343.78 ▼ 0.78% LITHIUM 69.22 ▼ 0.85% PETR4 43.42 ▲ 1.35% VALE3 76.28 ▲ 0.25% ITUB4 42.89 ▲ 0.35% BBDC4 18.43 ▲ 0.22% ABEV3 15.99 ▲ 0.19% BBAS3 21.35 ▲ 0.76% B3SA3 15.73 ▲ 0.64% WEGE3 47.20 ▲ 0.81% PRIO3 60.85 ▲ 1.48% SUZB3 43.32 ▲ 1.38% RENT3 37.61 ▼ 1.62% AZZA3 16.42 ▲ 3.53% CSAN3 4.07 ▲ 2.01% RAIZ4 0.26 — 0.00% PCAR3 2.59 ▼ 5.47% GMAT3 4.03 ▲ 1.26% PSSA3 54.70 ▲ 0.64% CVCB3 1.31 ▲ 0.77% POSI3 3.55 ▲ 0.85% SLCE3 13.38 ▲ 0.91% NATU3 8.38 ▲ 0.60% BRKM5 5.97 ▲ 0.67% RANI3 8.11 ▲ 1.00% CSNA3 4.84 ▼ 2.22% CMIN3 5.71 ▼ 0.17% USIM5 7.36 ▼ 2.52% GGBR4 24.98 — 0.00% ENEV3 26.31 ▲ 0.61% CPFE3 46.14 ▲ 0.11% CMIG4 11.34 ▲ 0.98% EQTL3 38.66 — 0.00% LREN3 13.60 ▲ 0.59% VIVT3 32.63 — 0.00% RAIL3 14.44 ▲ 1.12% KLABIN 18.25 ▲ 1.11% RAIA DROGASIL 18.48 ▲ 1.26% RDOR3 34.64 ▲ 0.64% HAPV3 11.28 ▲ 2.45% FLRY3 17.14 ▲ 1.00% SMTO3 14.52 ▲ 0.83% UGPA3 33.05 ▲ 0.39% VBBR3 36.05 ▲ 1.18% BBSE3 41.26 ▲ 0.98% BPAC11 56.80 ▲ 0.32% CURY3 30.09 ▼ 1.02% AERI3 2.15 ▲ 0.94% VIVARA 22.18 ▲ 0.09% COMPASS 24.84 — 0.00% VAMOS 3.34 ▼ 2.34% SANB11 28.62 ▲ 13.35% ASAI3 8.50 ▲ 1.07% SBSP3 27.70 ▲ 1.06% WALMEX 50.36 ▲ 0.34% GMEXICO 208.29 ▼ 2.20% FEMSA 221.95 ▲ 1.19% CEMEX 20.54 ▼ 0.73% GFNORTE 199.64 ▼ 0.32% BIMBO 62.08 ▲ 2.26% TELEVISA 9.79 ▼ 0.91% AMX 22.00 — 0.00% GAP 376.64 ▼ 1.08% ASUR 275.62 ▼ 0.34% OMA 231.05 ▼ 0.96% KOF 187.94 ▼ 0.14% GRUMA 258.23 ▼ 4.00% KIMBER 40.19 ▼ 0.17% SQM-B 62,700 ▼ 0.93% COPEC 6,350 ▲ 0.79% BSANTANDER 80.99 ▲ 0.36% FALABELLA 6,216 ▼ 0.06% ENELAM 87.99 ▲ 0.39% CENCOSUD 1,955 ▲ 0.51% CMPC 1,055 ▲ 2.43% BANCO CHILE 193.71 ▼ 1.57% LATAM AIR 24.74 ▼ 0.64% YPF 82,900 ▲ 1.94% GGAL 7,890 ▼ 1.56% PAMPA 5,555 ▲ 0.36% TXAR 655.50 ▲ 1.16% ALUAR 977.50 ▼ 0.20% TGS 10,050 ▲ 2.45% CEPU 2,396 ▼ 0.33% MIRGOR 16,350 ▼ 1.95% COME 44.03 ▼ 1.94% LOMA NEGRA 3,620 ▼ 1.76% BYMA 296.00 ▼ 0.34% TELECOM ARG 4,408 ▲ 2.14% ECOPETROL 16.77 ▼ 1.58% BANCOLOMBIA 92.52 ▼ 1.46% GRUPO AVAL 5.28 ▲ 2.75% CREDICORP 400.58 ▼ 0.42% SOUTHERN COPPER 182.71 ▼ 1.24% BUENAVENTURA 30.28 ▼ 4.96% MERCADOLIBRE 1,878 ▼ 0.41% NUBANK 14.33 ▼ 1.10% XP 17.06 ▼ 0.81% PAGSEGURO 9.64 ▼ 2.03% STONE 11.38 ▼ 0.48% GLOBANT 36.60 ▲ 0.58% TECNOGLASS 43.44 ▼ 0.34% GAP AIRPORT 217.35 ▼ 1.02% ASUR 275.62 ▼ 0.34% OMA AIRPORT 106.90 ▼ 1.10% AMX ADR 25.37 ▲ 0.18% FEMSA ADR 127.99 ▲ 0.97% CEMEX ADR 11.82 ▼ 0.92% PETROBRAS ADR 19.40 ▲ 1.46% VALE ADR 15.06 ▲ 0.47% ITAU ADR 8.46 ▲ 0.24% SANTANDER BR 5.67 ▲ 12.28% AMBEV ADR 3.11 ▼ 0.32% CSN 0.99 ▼ 2.42% GERDAU 4.96 — 0.00% LATAM ADR 52.75 ▼ 2.21% BTC 63,375 ▲ 0.97% ETH 1,878 ▲ 1.86% SOL 73.43 ▲ 2.18% XRP 1.08 ▲ 2.32% BNB 585.94 ▲ 1.91% ADA 0.19 ▲ 8.31% DOGE 0.07 ▲ 2.21% AVAX 6.53 ▲ 5.59% LINK 8.36 ▲ 3.72% DOT 0.80 ▲ 1.98% LTC 44.64 ▲ 1.03% BCH 212.39 ▲ 2.15% TRX 0.33 ▼ 0.40% XLM 0.17 ▲ 1.72% HBAR 0.07 ▲ 1.05% NEAR 1.71 ▲ 2.42% ATOM 1.27 ▲ 3.60% AAVE 91.55 ▲ 1.14% SELIC 14.25% EMBRAER 86.89 ▲ 0.87% EMBRAER ADR 68.33 ▲ 0.32% JBS 14.02 ▼ 1.89% JBS BDR 70.70 ▼ 2.01% MBRF3 17.54 ▼ 2.34% MBRFY 3.39 ▼ 2.31% INTER 5.60 ▼ 0.71% IBOV 177,999.00 ▲ 0.47% IPSA 11,016.85 ▼ 0.13% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,291,323 ▼ 0.41% COLCAP 2,392.10 ▲ 2.12% BVL PERÚ 57,890.85 — — USD/BRL 5.07 ▼ 0.02% USD/MXN 17.30 ▼ 0.26% USD/CLP 930.47 — 0.00% USD/COP 3,148 ▼ 0.08% USD/PEN 3.40 ▲ 0.15% USD/ARS 1,485 ▼ 0.03% USD/UYU 40.20 — 0.00% USD/PYG 5,931 — 0.00% USD/BOB 12.10 — 0.00% USD/DOP 58.11 ▲ 0.21% USD/CRC 448.40 — 0.00% USD/GTQ 7.62 — 0.00% USD/HNL 26.76 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 746.91 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.49 ▲ 0.56% USD/TTD 6.72 ▲ 0.86% EUR/BRL 5.86 ▲ 0.20% BRENT 90.12 ▲ 1.22% WTI 80.79 ▼ 4.58% IRON ORE 161.91 — — COPPER 6.54 ▲ 1.60% GOLD 4,132 ▲ 2.05% SILVER 58.52 ▲ 1.61% SOY 1,183 ▲ 0.90% CORN 460.75 ▲ 4.54% WHEAT 632.50 ▼ 1.06% COFFEE 313.55 ▼ 2.94% SUGAR 14.65 ▲ 1.52% ORANGE JUICE 153.35 ▲ 5.03% COTTON 81.20 ▲ 2.25% COCOA 5,537 ▲ 8.31% BEEF 227.25 ▼ 1.72% CATTLE 343.78 ▼ 0.78% LITHIUM 69.22 ▼ 0.85% PETR4 43.42 ▲ 1.35% VALE3 76.28 ▲ 0.25% ITUB4 42.89 ▲ 0.35% BBDC4 18.43 ▲ 0.22% ABEV3 15.99 ▲ 0.19% BBAS3 21.35 ▲ 0.76% B3SA3 15.73 ▲ 0.64% WEGE3 47.20 ▲ 0.81% PRIO3 60.85 ▲ 1.48% SUZB3 43.32 ▲ 1.38% RENT3 37.61 ▼ 1.62% AZZA3 16.42 ▲ 3.53% CSAN3 4.07 ▲ 2.01% RAIZ4 0.26 — 0.00% PCAR3 2.59 ▼ 5.47% GMAT3 4.03 ▲ 1.26% PSSA3 54.70 ▲ 0.64% CVCB3 1.31 ▲ 0.77% POSI3 3.55 ▲ 0.85% SLCE3 13.38 ▲ 0.91% NATU3 8.38 ▲ 0.60% BRKM5 5.97 ▲ 0.67% RANI3 8.11 ▲ 1.00% CSNA3 4.84 ▼ 2.22% CMIN3 5.71 ▼ 0.17% USIM5 7.36 ▼ 2.52% GGBR4 24.98 — 0.00% ENEV3 26.31 ▲ 0.61% CPFE3 46.14 ▲ 0.11% CMIG4 11.34 ▲ 0.98% EQTL3 38.66 — 0.00% LREN3 13.60 ▲ 0.59% VIVT3 32.63 — 0.00% RAIL3 14.44 ▲ 1.12% KLABIN 18.25 ▲ 1.11% RAIA DROGASIL 18.48 ▲ 1.26% RDOR3 34.64 ▲ 0.64% HAPV3 11.28 ▲ 2.45% FLRY3 17.14 ▲ 1.00% SMTO3 14.52 ▲ 0.83% UGPA3 33.05 ▲ 0.39% VBBR3 36.05 ▲ 1.18% BBSE3 41.26 ▲ 0.98% BPAC11 56.80 ▲ 0.32% CURY3 30.09 ▼ 1.02% AERI3 2.15 ▲ 0.94% VIVARA 22.18 ▲ 0.09% COMPASS 24.84 — 0.00% VAMOS 3.34 ▼ 2.34% SANB11 28.62 ▲ 13.35% ASAI3 8.50 ▲ 1.07% SBSP3 27.70 ▲ 1.06% WALMEX 50.36 ▲ 0.34% GMEXICO 208.29 ▼ 2.20% FEMSA 221.95 ▲ 1.19% CEMEX 20.54 ▼ 0.73% GFNORTE 199.64 ▼ 0.32% BIMBO 62.08 ▲ 2.26% TELEVISA 9.79 ▼ 0.91% AMX 22.00 — 0.00% GAP 376.64 ▼ 1.08% ASUR 275.62 ▼ 0.34% OMA 231.05 ▼ 0.96% KOF 187.94 ▼ 0.14% GRUMA 258.23 ▼ 4.00% KIMBER 40.19 ▼ 0.17% SQM-B 62,700 ▼ 0.93% COPEC 6,350 ▲ 0.79% BSANTANDER 80.99 ▲ 0.36% FALABELLA 6,216 ▼ 0.06% ENELAM 87.99 ▲ 0.39% CENCOSUD 1,955 ▲ 0.51% CMPC 1,055 ▲ 2.43% BANCO CHILE 193.71 ▼ 1.57% LATAM AIR 24.74 ▼ 0.64% YPF 82,900 ▲ 1.94% GGAL 7,890 ▼ 1.56% PAMPA 5,555 ▲ 0.36% TXAR 655.50 ▲ 1.16% ALUAR 977.50 ▼ 0.20% TGS 10,050 ▲ 2.45% CEPU 2,396 ▼ 0.33% MIRGOR 16,350 ▼ 1.95% COME 44.03 ▼ 1.94% LOMA NEGRA 3,620 ▼ 1.76% BYMA 296.00 ▼ 0.34% TELECOM ARG 4,408 ▲ 2.14% ECOPETROL 16.77 ▼ 1.58% BANCOLOMBIA 92.52 ▼ 1.46% GRUPO AVAL 5.28 ▲ 2.75% CREDICORP 400.58 ▼ 0.42% SOUTHERN COPPER 182.71 ▼ 1.24% BUENAVENTURA 30.28 ▼ 4.96% MERCADOLIBRE 1,878 ▼ 0.41% NUBANK 14.33 ▼ 1.10% XP 17.06 ▼ 0.81% PAGSEGURO 9.64 ▼ 2.03% STONE 11.38 ▼ 0.48% GLOBANT 36.60 ▲ 0.58% TECNOGLASS 43.44 ▼ 0.34% GAP AIRPORT 217.35 ▼ 1.02% ASUR 275.62 ▼ 0.34% OMA AIRPORT 106.90 ▼ 1.10% AMX ADR 25.37 ▲ 0.18% FEMSA ADR 127.99 ▲ 0.97% CEMEX ADR 11.82 ▼ 0.92% PETROBRAS ADR 19.40 ▲ 1.46% VALE ADR 15.06 ▲ 0.47% ITAU ADR 8.46 ▲ 0.24% SANTANDER BR 5.67 ▲ 12.28% AMBEV ADR 3.11 ▼ 0.32% CSN 0.99 ▼ 2.42% GERDAU 4.96 — 0.00% LATAM ADR 52.75 ▼ 2.21% BTC 63,375 ▲ 0.97% ETH 1,878 ▲ 1.86% SOL 73.43 ▲ 2.18% XRP 1.08 ▲ 2.32% BNB 585.94 ▲ 1.91% ADA 0.19 ▲ 8.31% DOGE 0.07 ▲ 2.21% AVAX 6.53 ▲ 5.59% LINK 8.36 ▲ 3.72% DOT 0.80 ▲ 1.98% LTC 44.64 ▲ 1.03% BCH 212.39 ▲ 2.15% TRX 0.33 ▼ 0.40% XLM 0.17 ▲ 1.72% HBAR 0.07 ▲ 1.05% NEAR 1.71 ▲ 2.42% ATOM 1.27 ▲ 3.60% AAVE 91.55 ▲ 1.14% SELIC 14.25% EMBRAER 86.89 ▲ 0.87% EMBRAER ADR 68.33 ▲ 0.32% JBS 14.02 ▼ 1.89% JBS BDR 70.70 ▼ 2.01% MBRF3 17.54 ▼ 2.34% MBRFY 3.39 ▼ 2.31% INTER 5.60 ▼ 0.71%
since 2009
Monday, August 3, 2026

Covid-19 Brazil

Analysis: China Unleashed Retaliation Over Reports on Efficacy of One of Its Vaccines

By · January 19, 2021 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Ghosts everywhere. Since the outbreak of the coronavirus pandemic in Wuhan, Hubei, to this day, Xi Jinping’s regime believes there is an international campaign to discredit the global economic giant. That is the argument used to justify the diplomatic hostility they have shown throughout 2020 and which seems to be ongoing this year. Now this ghost emerges in Latin America. More specifically in Brazil.

Ghosts everywhere. Since the outbreak of the coronavirus pandemic in Wuhan, Hubei, to this day, Xi Jinping's regime believes there is an international campaign to discredit the global economic giant
China’s President Xi Jinping. (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

It occurred after Brazilian health and scientific officials reported that the Chinese-made Coronavac vaccine proved 50.38% effective, far below other Western vaccines and what had been previously reported in China. This was announced last January 12th by São Paulo’s Butantan Institute -one of the most prestigious in the country- when applying for the vaccine’s emergency use authorization.

However, the report infuriated Beijing. The president of the Sinovac laboratory, Yin Weidong, immediately stated that the antidote was highly effective, thereby challenging the Brazilian test. Yin argued that trials in Brazil had found it to be 100% effective in preventing severe cases of COVID-19 and that the company was expanding its production capacity to meet domestic and foreign demand.

Notwithstanding these efforts, the Asian country’s leadership intended to restore “honor” to its vaccine. It found no better way than to deploy its “Wolf Warrior diplomacy”, i. e. to attack its rivals. In this case, other vaccines and the companies behind them. It is particularly striking given that Xi Jinping had previously called for “solidarity and cooperation” among the world’s nations to secure vaccines for everyone.

Chinese diplomacy and the propaganda machine targeted Pfizer, Moderna and AstraZeneca. It began by claiming that the Chinese vaccines were easier to store, distribute and administer than others made in the United States and Europe. And it insisted that its vaccines are around 80 percent effective. The figures are unclear: according to Turkey, the CoronaVac is 91.25 % effective; according to Indonesia, 65.3%; and according to China, 78% effective. No one knows what the real number is.

Some countries which had pre-purchased the doses requested Sinovac for additional data and suspended shipments for the time being. However, vaccine data is under the control of the Beijing regime. What documents will be sent to countries looking for assurances on Chinese vaccines remains a mystery.

Meanwhile, Xi Jinping’s officials are starting to attack the West and its media. One of their spokesmen is the Global Times’ editor-in-chief, Hu Xinjin. The media outlet is a body of the Chinese Communist Party (CCP). “If you look at the websites of major U.S. and Western media, virtually all the news you read about the Chinese-made vaccine is negative. The press wants to destroy the Chinese vaccine’s reputation, hoping that the world will wait for Pfizer and other US and Western companies to produce surplus vaccines and finally be immunized,” Hu said. Victimization is one of the tools the regime uses to ignite nationalism among its followers.

“Hu has led the way in defending Chinese-produced vaccines, not by establishing their efficacy, but by trying to topple the reputation of other candidates, particularly the ones produced by American Pfizer,” said CNN analyst James Griffiths.

The CCP newspaper columnist also wrote an editorial in which he accused the Western media of failing to publish anything about the deaths in Norway that supposedly resulted from immunization with the Pfizer doses.

However, following an internal investigation, Norwegian officials established that there was no link between the deaths and vaccination of the elderly. “All these patients had serious underlying diseases,” said Steinar Madsen, medical director of the Norwegian Medicines Agency. “We can’t say that people are dying because of the vaccine. We can say that it may be a coincidence. It is difficult to prove that the vaccine is the direct cause.”

China’s state-run CGTN TV network took it upon itself to taint Western vaccines and accuse European, US and international media of withholding information about what was happening in Norway. One of the main instigators of accusations against Pfizer was one of Beijing’s top Foreign Ministry spokespersons, Xhao Lijian. He used Twitter to share a dozen messages from anchor Liu Xin.

Liu was outraged by what he believed was insufficient coverage of the deaths in Norway and others in Germany. He directly accused the media, international news agencies and Pfizer of being behind the campaign and the alleged cover-up. One of the tweets said, “It cannot be independently verified, but it is worrying: ten deaths in Germany a few days after getting the Pfizer/BioNTech vaccines”. Strange for a journalist to provide information while acknowledging it has not been verified. The Beijing Foreign Ministry’s spokesperson retweeted the reckless post.

“Did any of the major American or European media cover the story? Just think if it was found that 13 people had died from Chinese-made vaccines, it would have made headlines everywhere,” Liu was again outraged, a sentiment shared by Xhao and his nearly 900,000 followers.

According to the CNN analyst Griffiths, news about deaths and severe reactions from vaccination should be taken responsibly by the media. Moreover, the news should be confirmed before being published. “Journalists, be it in China, the United States, or anywhere else in the world, have a very good reason not to rush to report on alleged vaccine-related deaths. In fact, some media have been criticized for overreporting allergic reactions to vaccines or reporting the deaths of recently vaccinated people with no evidence of any link to the shot,” said Griffiths. Such self-criticism came from the free press, not state-run.

Griffiths also quoted an expert in the field. Derek Lowe is a pharmaceutical industry expert. He recently wrote that “if you take 10 million people, you would expect to see about 14,000 deaths from heart attacks, strokes, cancer and other common causes of death over the next two months.”

“While articles about allergic reactions and vaccine-related deaths may place the issue in the proper context, it is often difficult for headlines to do so. This creates the risk that people will only see that there have been deaths and be under the mistaken impression that coronavirus vaccines are dangerous,” the North American news network analyst pointed out.

Source: infobae

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.